Molecular cloning and functional characterization of the upstream promoter region of the human p73 gene

DNA Research

Volumn 6, Issue 5, 1999, Pages 347-351

  Ding, Yi ^a   Inoue, Toshiaki ^a   Kamiyama, Jun ^a   Tamura, Yutaka ^a   Ohtani Fujita, Naoko ^a,b   Igata, Eiji ^a   Sakai, Toshiyuki ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

CpG island; Luciferase assay; p73; Promoter

Indexed keywords

DNA BINDING PROTEIN; LUCIFERASE; NUCLEAR PROTEIN; TUMOR SUPPRESSOR PROTEIN; TUMOR SUPPRESSOR PROTEIN P73;

ARTICLE; CPG ISLAND; DNA BASE COMPOSITION; DNA SEQUENCE; GENETICS; HUMAN; METABOLISM; MOLECULAR CLONING; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PROMOTER REGION; TUMOR SUPPRESSOR GENE;

BASE COMPOSITION; BASE SEQUENCE; CLONING, MOLECULAR; CPG ISLANDS; DNA-BINDING PROTEINS; GENES, TUMOR SUPPRESSOR; HUMANS; LUCIFERASES; MOLECULAR SEQUENCE DATA; NUCLEAR PROTEINS; PROMOTER REGIONS (GENETICS); SEQUENCE ANALYSIS, DNA; TUMOR SUPPRESSOR PROTEINS;

EID: 0033615366     PISSN: 13402838     EISSN: None     Source Type: Journal    
DOI: 10.1093/dnares/6.5.347     Document Type: Article

References (21)

1. Kaghad, M., Bonnet, H., Yang, A., Creancier, L., Biscan, J. C., Valent, A., Minty, A., Chalon, P., Lelias, J. M., Dumont, X., Ferrara, P., McKeon, F., and Caput, D. 1997, Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers, Cell, 90, 809-819.
2. Jost, C. A., Marin, M. C., and Kaelin, Jr W. G. 1997, p73 is a human p53-related protein that can induce apoptosis, Nature, 389, 191-194.
3. Zhu, J. H., Jiang, J. Y., Zhou, W. J., and Chen, X. B. 1998, The potential tumor suppresser p73 differentially regulates cellular p53 target genes, Cancer Res., 58, 5061-5065.
4. Nomoto, S., Haruki, N., Kondo, M., Konishi, H., Takahashi, T., Takahashi, T., and Takahashi, T. 1998, Search for mutations and examination of allelic expression imbalance of the p73 gene at Ip36.33 in human lung cancers, Cancer Res., 58, 1380-1383.
5. Mai, M., Yokomizo, A., Qian, C. P., Yang, P., Tindall, D. J., Smith, D. I., and Liu, W. G. 1998, Activation of p73 silent allele in lung cancer, Cancer Res., 58, 2347-2349.
6. Tsao, H., Zhang, X., Majewski, P., and Haluska, F. G. 1999, Mutational and expression analysis of the p73 gene in melanoma cell lines, Cancer Res., 59, 172-174.
7. Nimura, Y., Mihara, M., Ichimiya, S., Sakiyama, S., Seki, N., Ohira, M., Nomura, N., Fujimori, M., Adachi, W., Amano, J., He, M., Ping, Y. M., and Nakagawara, A. 1998, p73, a gene related to p53, is not mutated in esophageal carcinomas, Int. J. Cancer, 78, 437-440.
8. Stirewalt, D. L., Clurman, B., Appelbaum, F. R., Willman, C. L., and Radich, J. P. 1999, p73 mutations and expression in adult de novo acute myelogenous leukemia, Leukemia, 13, 985-990.
9. Mai, M., Qian, C. P., Yokomizo, A., Tindall, D. J., Bostwick, D., Polychronakos, G., Smith, D. I., and Liu, W. G. 1998, Loss of imprinting and allele switching of p73 in renal cell carcinoma, Oncogene, 17, 1739-1741.
10. Yokomizo, A., Mai, M., Tindall, D. J., Cheng, L., Bostwick, D. G., Naito, S., Smith, D. I., and Liu, W. G. 1999, Overexpression of the wild type p73 gene in human bladder cancer, Oncogene, 18, 1629-1633.
11. Chi, S. G., Chang, S. G., Lee, S. J., Lee, C. H., Kim, J. I., and Park, J. H. 1999, Elevated and biallelic expression of p73 is associated with progression of human bladder cancer, Cancer Res., 59, 2791-2793.
12. Wingender, E., Dietze, P., Karas, H., and Knuppel, R. 1996, TRANSFA: a database on transcription factor and their DNA binding sites, Nucleic Acids Res., 24, 238-241.
13. Milanesi, L., Muselli, M., and Arrigo, P. 1996, Hamming-Clustering method for signals prediction in 5′ and 3′ regions of eukaryotic genes, Comput Appl Biosci., 12, 399-404.
14. Gardiner-Garden, M. and Frommer, M. 1987, CpG islands in vertebrate genomes, J. Mol. Biol., 196, 261-282.
15. Antequera, F. and Bird, A. 1993, Number of CpG islands and genes in human and mouse, Proc. Natl. Acad. Sci. USA, 90, 11995-11999.
16. Mai, M., Huang, H. J., Reed, G., Qian, C. P., Smish, J. S., Alderete, B., Jenkins, R., Smish, D. I., and Liu, W. G. 1998, Genomic organization and mutation analysis of p73 in oligodendrogliomas with chromosome 1 p-arm deletions, Genomics, 51, 359-363.
17. Corn, P. G., Kuerbitz, S. J., van Noesel, M. M., Esteller, M., Compitello, N., Baylin, S. B., and Herman, J. G. 1999, Transcriptional silencing of the p73 gene in acute lymphoblastic leukemia and Burkitt's lymphoma is associated with 5′ CpG island methylation, Cancer Res., 59, 3352-3356.
18. Kawano, S., Miller, C. W., Gombart, A. F., Bartram, C. R., Matsuo, Y., Asou, H., Sakashita, A., Said, J., Tatsumi, E., and Koeffler, H. P. 1999, Loss of p73 gene expression in leukemia/lymphomas due to hypermethylation, Blood, 94, 1113-1120.
19. Bartolomei, M. S., Webber, A. L., Brunkow, M. E., and Tilghman, S. M. 1993, Epigenetic mechanisms underlying the imprinting of the mouse H19 gene, Genes Dev., 7, 1663-1673.
20. Sakai, T. 1996, Molecular cancer epidemiology-The present status and future possibilities, Jpn. J. Hyg., 50, 1036-1046.
21. Sambrook, E. F., Fritsch, T., and Maniatis, T. 1989, Molecular cloning: A laboratory manual, 2nd edn., Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.